<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Psychol Res Behav Manag</journal-id><journal-id journal-id-type="iso-abbrev">Psychol Res Behav Manag</journal-id><journal-id journal-id-type="publisher-id">Psychology Research and Behavior Management</journal-id><journal-title-group><journal-title>Psychology Research and Behavior Management</journal-title></journal-title-group><issn pub-type="epub">1179-1578</issn><publisher><publisher-name>Dove Medical Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">25061340</article-id><article-id pub-id-type="pmc">4079627</article-id><article-id pub-id-type="doi">10.2147/PRBM.S52352</article-id><article-id pub-id-type="publisher-id">prbm-7-167</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Research</subject></subj-group></article-categories><title-group><article-title>The influence of psychoeducation on regulating biological rhythm in a sample of patients with bipolar II disorder: a randomized clinical trial</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Faria</surname><given-names>Augusto Duarte</given-names></name><xref ref-type="aff" rid="af1-prbm-7-167">1</xref></contrib><contrib contrib-type="author"><name><surname>de Mattos Souza</surname><given-names>Luciano Dias</given-names></name><xref ref-type="aff" rid="af2-prbm-7-167">2</xref></contrib><contrib contrib-type="author"><name><surname>de Azevedo Cardoso</surname><given-names>Taiane</given-names></name><xref ref-type="aff" rid="af2-prbm-7-167">2</xref></contrib><contrib contrib-type="author"><name><surname>Pinheiro</surname><given-names>Karen Amaral Tavares</given-names></name><xref ref-type="aff" rid="af2-prbm-7-167">2</xref></contrib><contrib contrib-type="author"><name><surname>Pinheiro</surname><given-names>Ricardo Tavares</given-names></name><xref ref-type="aff" rid="af2-prbm-7-167">2</xref></contrib><contrib contrib-type="author"><name><surname>da Silva</surname><given-names>Ricardo Azevedo</given-names></name><xref ref-type="aff" rid="af2-prbm-7-167">2</xref></contrib><contrib contrib-type="author"><name><surname>Jansen</surname><given-names>Karen</given-names></name><xref ref-type="aff" rid="af2-prbm-7-167">2</xref><xref ref-type="corresp" rid="c1-prbm-7-167"/></contrib></contrib-group><aff id="af1-prbm-7-167"><label>1</label>Department of Clinical and Health Psychology, Universidade Federal do Rio Grande &#x02013; FURG, Rio Grande, RS, Brazil</aff><aff id="af2-prbm-7-167"><label>2</label>Health and Behavior Postgraduate Program, Universidade Cat&#x000f3;lica de Pelotas &#x02013; UCPEL, Pelotas, RS, Brazil</aff><author-notes><corresp id="c1-prbm-7-167">Correspondence: Karen Jansen, Universidade Cat&#x000f3;lica de Pelotas, Rua F&#x000e9;lix da Cunha, 412, Pelotas, RS, Brazil, 96010-000, Tel +55 532 128 8012, Fax +55 532 128 8298, Email <email>karenjansen315@hotmail.com</email></corresp></author-notes><pub-date pub-type="collection"><year>2014</year></pub-date><pub-date pub-type="epub"><day>26</day><month>6</month><year>2014</year></pub-date><volume>7</volume><fpage>167</fpage><lpage>174</lpage><permissions><copyright-statement>&#x000a9; 2014 Faria et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution &#x02013; Non Commercial (unported, v3.0) License</copyright-statement><copyright-year>2014</copyright-year><license><license-p>The full terms of the License are available at <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.</license-p></license></permissions><abstract><sec><title>Introduction</title><p>Changes in biological rhythm are among the various characteristics of bipolar disorder, and have long been associated with the functional impairment of the disease. There are only a few viable options of psychosocial interventions that deal with this specific topic; one of them is psychoeducation, a model that, although it has been used by practitioners for some time, only recently have studies shown its efficacy in clinical practice.</p></sec><sec><title>Aim</title><p>To assess if patients undergoing psychosocial intervention in addition to a pharmacological treatment have better regulation of their biological rhythm than those only using medication.</p></sec><sec><title>Method</title><p>This study is a randomized clinical trial that compares a standard medication intervention to an intervention combined with drugs and psychoeducation. The evaluation of the biological rhythm was made using the Biological Rhythm Interview of Assessment in Neuropsychiatry, an 18-item scale divided in four areas (sleep, activity, social rhythm, and eating pattern). The combined intervention consisted of medication and a short-term psychoeducation model summarized in a protocol of six individual sessions of 1 hour each.</p></sec><sec><title>Results</title><p>The sample consisted of 61 patients with bipolar II disorder, but during the study, there were 14 losses to follow-up. Therefore, the final sample consisted of 45 individuals (26 for standard intervention and 19 for combined). The results showed that, in this sample and time period evaluated, the combined treatment of medication and psychoeducation had no statistically significant impact on the regulation of biological rhythm when compared to standard pharmacological treatment.</p></sec><sec><title>Conclusion</title><p>Although the changes in biological rhythm were not statistically significant during the time period evaluated in this study, it is noteworthy that the trajectory of the score showed a trend towards improvement, which may indicate a positive impact on treatment, though it may take a longer time than expected.</p></sec></abstract><kwd-group><title>Keywords</title><kwd>neuropsychiatry</kwd><kwd>melatonin</kwd><kwd>depression</kwd><kwd>mania</kwd><kwd>lithium</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Changes in biological rhythm are among the various characteristics of bipolar disorder (BD) and have long been associated with the functional impairment of the disease,<xref rid="b1-prbm-7-167" ref-type="bibr">1</xref> with damages that may persist even during remission, such as subsyndromic symptoms and risk of relapse.<xref rid="b2-prbm-7-167" ref-type="bibr">2</xref> These changes occur mainly due to sleep disturbances<xref rid="b3-prbm-7-167" ref-type="bibr">3</xref> (that can be related to allelic mutations on clock genes<xref rid="b4-prbm-7-167" ref-type="bibr">4</xref>), changes in routine,<xref rid="b1-prbm-7-167" ref-type="bibr">1</xref> and stressful life events.<xref rid="b5-prbm-7-167" ref-type="bibr">5</xref> It has also been suggested that bipolar subjects secrete abnormal levels of melatonin and are hypersensitive to light, which can affect their sleep patterns.<xref rid="b6-prbm-7-167" ref-type="bibr">6</xref> Disruptions in the biological rhythm of subjects with BD can trigger acute episodes; for example, there are clear links between sleep disturbances and mania.<xref rid="b7-prbm-7-167" ref-type="bibr">7</xref> A poor repertoire of coping skills to face social rhythm disruptions may compromise the maintenance of a euthymic state of the subjects, resulting in a series of failed attempts of regulation.</p><p>Although pharmacotherapy is an indispensable primary option for the treatment of BD, it is interesting to offer viable options of psychosocial interventions in order to improve pharmacological treatment adherence, coping skills, and the patient&#x02019;s quality of life.<xref rid="b8-prbm-7-167" ref-type="bibr">8</xref> These interventions are increasingly recognized as an essential component in the treatment of BD.<xref rid="b9-prbm-7-167" ref-type="bibr">9</xref>,<xref rid="b10-prbm-7-167" ref-type="bibr">10</xref> Successful psychosocial interventions for unipolar depression such as adjunctive family therapy,<xref rid="b11-prbm-7-167" ref-type="bibr">11</xref>,<xref rid="b12-prbm-7-167" ref-type="bibr">12</xref> cognitive behavioral therapy,<xref rid="b13-prbm-7-167" ref-type="bibr">13</xref> and interpersonal and social rhythm therapy<xref rid="b14-prbm-7-167" ref-type="bibr">14</xref> were adapted for BD and evaluated by trials, and are associated with greater symptom stabilization and change of habits. However, not all are equally effective, and the long-term effects do not indicate a significant improvement over conventional therapy.</p><p>Among all psychosocial interventions, psychoeducation (PE) has been one of the most used and is recommended by several guidelines<xref rid="b15-prbm-7-167" ref-type="bibr">15</xref>,<xref rid="b16-prbm-7-167" ref-type="bibr">16</xref> as a first choice for BD due to its appeal to a wider population and because of its straightforward and cost-effective profile. PE is recommended for pharmacological adherence enhancement, knowledge, and awareness of the disease.<xref rid="b17-prbm-7-167" ref-type="bibr">17</xref> It is particularly helpful for subjects to learn how to detect prodromal signs of the disease and, consequently, to prevent relapses.<xref rid="b18-prbm-7-167" ref-type="bibr">18</xref>,<xref rid="b19-prbm-7-167" ref-type="bibr">19</xref> Although PE is an intervention model that has been used by practitioners for some time, only recently have studies with reliable methodology shown its efficacy in clinical practice.<xref rid="b20-prbm-7-167" ref-type="bibr">20</xref>&#x02013;<xref rid="b23-prbm-7-167" ref-type="bibr">23</xref> A recent systematic review by Batista<xref rid="b24-prbm-7-167" ref-type="bibr">24</xref> identified a total of 13 randomized clinical trials evaluating PE in BD. Briefly, these studies evaluated PE in different samples (BD-only subject, relatives/caregivers, or both), both in groups and individually. The number of sessions ranged from five to 21 meetings, and the follow-ups ranged from 6 months to 5 years. The results of the review indicate that PE is an intervention particularly effective in decreasing the relapse rate (both manic and depressive) and in improving overall social functioning. However, as pointed out by the authors, the mechanism of action of PE remains unknown. Their primary hypothesis states that teaching lifestyle regularity is the main aspect and may play a role in relapse prevention due to early detection of prodromal symptoms.</p><p>BD is a neuroprogressive disease, longitudinally associated with increased severity and an accelerated disability. One of the concepts that attempts to explain why BD worsens over time is allostatic load (AL). AL discusses the cumulative effects of an overload of the adaptative systems due to the typical chronic overactivity of the disease.<xref rid="b25-prbm-7-167" ref-type="bibr">25</xref> The AL increases progressively as stressors and mood episodes occur over time, and is connected to the cognitive impairment of BD, which includes attention, executive function, and verbal memory.<xref rid="b26-prbm-7-167" ref-type="bibr">26</xref></p><p>Since the first mood episodes are happening earlier (the typical age of onset is 23 years) and severe symptoms are unfolding earlier, there is a possibility of higher severity of BD in younger generations.<xref rid="b27-prbm-7-167" ref-type="bibr">27</xref> We wondered whether a psychosocial intervention applied in younger patients, who have a shorter disease duration, fewer mood episodes, and reduced cognitive impairment, can have a different impact on regulating their biological rhythms. For this purpose, we carried out a study with young adults, aged between 18&#x02013;29 years, diagnosed with BD, in which we compared a standard intervention (pharmacological with mood stabilizers) and a combined intervention of drugs and a short-term PE model.<xref rid="b28-prbm-7-167" ref-type="bibr">28</xref> Although studies that showed the effectiveness of PE for the treatment of BD<xref rid="b18-prbm-7-167" ref-type="bibr">18</xref>,<xref rid="b29-prbm-7-167" ref-type="bibr">29</xref> had a similar design (randomized clinical trial), the sampling and the intervention design were significantly different. We do not know of any study that has evaluated a short-term individual PE intervention for bipolar subjects in a sample formed exclusively of young adults with no previous treatment.</p></sec><sec><title>Aim</title><p>The aim of this study was to assess if subjects undergoing psychosocial intervention in addition to a pharmacological treatment could have better regulation of their biological rhythms than those who were only using medication.</p></sec><sec sec-type="methods"><title>Method</title><sec sec-type="methods"><title>Design and setting</title><p>This study is a randomized clinical trial that evaluated the influence of PE on regulating the biological rhythm of individuals with Bipolar II Disorder by comparing a standard medication intervention to an intervention combined with drugs and PE. The project was approved by the Ethics Committee on Research of Catholic University of Pelotas (UCPel), according to protocol No 2009/24, and all participants signed the informed consent.</p><p>In order to ensure the necessary sample size to estimate the effectiveness of the interventions, the trial was advertised in public health care units, psychosocial care centers, outpatient clinics, and city hospitals. The subjects recruited in these places were selected as follows. Those who agreed to participate were evaluated by a semi-structured clinical interview (SCID-I [Structured Clinical Interview for DSM Disorders]) in order to ensure diagnostic reliability. This interview model is based on the <italic>Diagnostic and Statistical Manual of Mental Disorders</italic> 4th Edition &#x02013; Text Revision, with a translation and adaptation to Portuguese that presents, in general, good reliability, with an excellent Kappa coefficient (0.87) for mood disorders.<xref rid="b30-prbm-7-167" ref-type="bibr">30</xref> The interviews were conducted by two PhD students, who underwent intensive training under the supervision of a senior researcher. After the bipolar II diagnosis was validated, the subjects were referred to the psychiatric services of the public health system. However, due to the difficulty in obtaining medication in the public health system in the city of Pelotas, a city in southern Brazil with a population of 350,000, a psychiatrist had to be assigned to the research team and the subjects were referred to the psychiatric outpatient clinic of the Health Campus of UCPel. The medicated subjects that matched the inclusion criteria (aged between 18&#x02013;29 years, a validated clinical diagnosis of bipolar II according to SCID, and gave their informed consent) were invited to participate in the trial. Those with suicide risk and/or using illegal drugs were not included and were offered treatment at a specialized outpatient facility. The Economic Index was assessed with the National Economic Index,<xref rid="b31-prbm-7-167" ref-type="bibr">31</xref> based on the total of material goods and the householders&#x02019; schooling, among other items. The socioeconomic classes were divided into three levels (high, intermediate, and low) for the Brazilian population according to the 2000 Demographic Census.</p></sec><sec><title>Outcome measures</title><p>The severity of depressive symptoms was measured with the Hamilton Depression Rating Scale, a 17-item scale that enables the creation of a discrete variable, in which the higher scores correspond to a higher severity of the symptoms. The internal consistency ranges from 0.83 to 0.94. The scale reliability between raters has been consistent in several studies.<xref rid="b32-prbm-7-167" ref-type="bibr">32</xref> To assess the intensity of manic symptoms, we utilized the Young Mania Rating Scale, an eleven-item scale chosen for its high reliability in measuring severity levels of mania and validity coefficient. The Brazilian validated version,<xref rid="b33-prbm-7-167" ref-type="bibr">33</xref> which has an even better reliability level than the original, had its internal consistency assessed by Cronbach&#x02019;s &#x003b1;, calculated using analysis of variance applied to the eleven items of the scale. From the resulting covariance matrix, &#x003b1; =0.67 was obtained for the scale as a whole, and &#x003b1; =0.72 for each standardized item (<italic>P</italic>&#x0003c;0.001).</p><p>The evaluation of the biological rhythm was made using the Biological Rhythm Interview of Assessment in Neuropsychiatry (BRIAN). This scale was designed to offer a reliable, validated, and standardized measure of biological rhythm, with scores clinically understandable for researchers. The 18 items are divided in four specific areas (sleep, activity, social rhythm, and eating pattern) that are rated using a four-point scale: 1 (no difficulty) to 4 (very difficult). The validity and reliability of the Portuguese BRIAN version are described by Giglio et al,<xref rid="b34-prbm-7-167" ref-type="bibr">34</xref> including information about its factor analysis and how the areas were selected. All the outcome measures were assessed in two different time points: baseline and postintervention.</p></sec><sec><title>Randomization</title><p>Participants were randomly divided into two groups using sealed envelopes: one group received a short-term PE model<xref rid="b28-prbm-7-167" ref-type="bibr">28</xref> and medication (combined intervention), and the other received only medication (standard intervention). The randomization was made by a team member who did not participate in any of the previous stages of the study. Those who administered the intervention were not blind as to the absence or presence of PE associated with drug intervention. However, blinding of the baseline and postintervention evaluators was guaranteed (they were always blinded to subject allocation) by changing the team for each evaluation time point.</p></sec><sec><title>Interventions</title><p>The standard intervention was pharmacological treatment with mood stabilizers. The subjects assigned to the standard intervention followed the treatment prescribed by psychiatrists (from the public health system or the research team) according to their needs. The combined intervention consisted of medication and a short-term PE model adapted from the <italic>Psychoeducation Manual for Bipolar Disorder</italic> developed by Colom and Vieta.<xref rid="b28-prbm-7-167" ref-type="bibr">28</xref> The model was summarized in a protocol of six individual sessions of 1 hour each. Generally, the sessions occurred in the following order: the first introduced the therapist to the patient and explained the treatment guidelines, confidentiality issues, the PE protocol (&#x0201c;What is it&#x0201d; and &#x0201c;What it is not&#x0201d;), and the general concepts of BD (&#x0201c;What is mood?&#x0201d;). The second session explained the biological nature of BD, mania and hypomania concepts, and the social stigma related to the disease in order to modify inadequate understanding and feelings of guilt. The third session involved depressive symptoms, and the fourth instructed the patient to detect warning signs of recurrence (through the identification of prodromal behaviors) and the benefits of doing so (developing a predefined action plan with techniques and resources). The fifth session provided the patient with options of what to do when an episode was detected, emphasizing the importance of adherence to pharmacological treatment and contact with the psychiatrist, The sixth and final session summarized everything that was explained in the previous sessions, reinforcing aspects with which the patient had difficulty. The intervention was carried out by psychology undergraduates (in their final year) who were trained and supervised by a qualified and experienced researcher.</p><p>Regarding the pharmacological treatment in both groups, primarily only medication provided by the Brazilian Public Health System was prescribed, in order to facilitate the continuity of treatment after the end of the study. Lithium was the most commonly used medication, and was prescribed alone or in combination with other drugs such as anticonvulsants, antidepressants, neuroleptics, and benzodiazepines, according to the needs of each patient. There were no statistically significant differences between groups for the use of medication, combined or not.</p></sec><sec sec-type="methods"><title>Statistical analysis</title><p>After coding the baseline and postintervention assessment tools, data were entered twice in the Epi-Info 6.04d software (Centers for Disease Control and Prevention, Atlanta, GA, USA) with consistency checked using the validate command. After that, the data were transferred to SPSS 13.0 software (IBM Corporation, Armonk, NY, USA) for statistical analyses, which is presented in three tables. <xref ref-type="table" rid="t1-prbm-7-167">Table 1</xref> describes the characteristics of the sample (baseline) between the two intervention groups. The data are presented in absolute and relative frequencies for qualitative variables with chi-square tests for differences between groups. Quantitative variables are described as mean and standard deviation, since they were normally distributed in the Gaussian curve. The difference between means was verified by <italic>t</italic>-test. <xref ref-type="table" rid="t2-prbm-7-167">Table 2</xref> shows, by paired <italic>t</italic>-test, the difference between the mean and confidence interval of the difference in symptom scores and biological rhythm of the baseline and postintervention presented in the whole group, the standard intervention group, and the combined intervention group. We also present the effect sizes of each of the associations studied.</p><p>In <xref ref-type="table" rid="t3-prbm-7-167">Table 3</xref>, linear regression was used to verify the difference between the remission scores of depressive and manic symptoms, as well the biological rhythm regulation between the proposed intervention groups. In the same table we can observe the coefficient of linear regression and the confidence interval of 95%, both crude and adjusted for economic index. The data shown refer to the combined intervention, using the standard intervention as reference. For all the statistical tests, significant associations were considered at a 95% significance level (<italic>P</italic>&#x0003c;0.05).</p></sec><sec sec-type="subjects"><title>Participants</title><p>A total of 282 young adults were tested for inclusion in the trial. Among these, 220 did not meet the criteria and were referred to the Public Health System. The sample at this point consisted of 61 bipolar II subjects, 29 for standard intervention and 32 for combined intervention. During the study, there were 14 losses to follow-up (three from standard intervention and eleven from combined intervention). In addition, one patient refused to take part in the PE and another was excluded from the study due to illicit substance abuse during the PE period. Therefore, the final sample consisted of 45 individuals (26 for standard intervention and 19 for combined intervention) (<xref ref-type="fig" rid="f1-prbm-7-167">Figure 1</xref>). The participants were recruited between July 2010 and June 2012, and the final evaluations took place from November 2010 to September 2012.</p></sec></sec><sec sec-type="results"><title>Results</title><p>In this sample, the majority of the participants were women, with an average age of 24 years, and 12 years of schooling. Randomization was effective and the distribution was homogeneous in all respects except the economic index, which showed significant difference between groups (<italic>P</italic>=0.041). Although the groups were similar as to the presence of symptoms at baseline, the social domain (<italic>P</italic>&#x0003c;0.001) and the total score (<italic>P</italic>=0.040) of the BRIAN scale were different between groups. Other baseline information is described in <xref ref-type="table" rid="t1-prbm-7-167">Table 1</xref>.</p><p>Regarding the influence of the interventions on mood symptoms, according to the intention-to-treat analysis (n=61), both groups showed remission of depressive symptoms (standard <italic>P</italic>=0.006; combined <italic>P</italic>=0.041), but none showed a statistically significant reduction of manic symptoms. Unlike we expected, there was no statistically significant influence of PE on biological rhythm between the evaluations. Only the standard intervention group showed improvement in the BRIAN domains: sleep (<italic>P</italic>=0.012), activity (<italic>P</italic>&#x0003c;0.001), social rhythm (<italic>P</italic>=0.002) and total score (<italic>P</italic>=0.001). All significant associations presented effect sizes between moderate and strong (<xref ref-type="table" rid="t2-prbm-7-167">Table 2</xref>). There was no difference in depressive symptoms remission among intervention models after the linear regression. On the other hand, there was a tendency of manic symptoms remission in the combined intervention model after adjustment for economic index (<italic>P</italic>=0.061). However, a strong biological rhythm regulation was found in the standard intervention group (when compared to combined), regardless of the setting (<xref ref-type="table" rid="t3-prbm-7-167">Table 3</xref>).</p></sec><sec><title>Discussion and methodological considerations</title><p>The results showed that, in this sample and time period evaluated, the combined treatment of medication and PE had no statistically significant impact on the regulation of biological rhythm when compared to standard pharmacological treatment. As the hypothesis investigated was not confirmed, despite the methodological precision in which the study was conducted, relevant research questions emerge for future studies. The economic status, for example, which was relevant mainly in the combined intervention group, has a described negative effect on the response to PE intervention.<xref rid="b35-prbm-7-167" ref-type="bibr">35</xref></p><p>The sample size, a limitation of our study, reflects the struggle in finding bipolar subjects willing to enter an investigation when it was not part of a service in which they already participate. A possible reason for this is that because those subjects had only few episodes, they were not yet aware of the importance of treatment. Two other limitations of the study should be noted: the lack of control of the medication used in the standard intervention and a need for emphasis on the importance of a life routine of the subjects on the PE model. While these limitations may have influenced the study in some way, we believe, especially in the medication issue, that the success of randomization has dissipated the effects.</p><p>How PE works is worth questioning. In this particular case, when the subjects answered the questionnaires after the intervention, the PE may have helped them to become more sensitive in detecting warning signs and more self-demanding in their answers, which is common in mania and hypomania,<xref rid="b19-prbm-7-167" ref-type="bibr">19</xref> and consequently, lower scores were obtained. Also, the treatment duration, time period evaluated, and number of sessions probably played a key role in the results obtained. Experimental evidence shows that compact models can be effective;<xref rid="b36-prbm-7-167" ref-type="bibr">36</xref> however, there is a study design similar to ours<xref rid="b35-prbm-7-167" ref-type="bibr">35</xref> which confirms that 16 sessions (more than twice the number used in this study) did not obtain any changes. Maybe the results we obtained were not because of the number of sessions, but considering PE characteristics, that the effect happens over time and may appear in follow-up evaluations. In this sense, its longitudinal effectiveness in prophylaxis has already been proven.<xref rid="b37-prbm-7-167" ref-type="bibr">37</xref></p></sec><sec><title>Conclusion</title><p>Although the changes in biological rhythm were not statistically significant during the time period evaluated in this study, it is noteworthy that the trajectory of the score showed a trend towards improvement, which may indicate a contribution even though it may take a longer time to appear than expected. PE is an active component of successful psychosocial interventions for BD,<xref rid="b38-prbm-7-167" ref-type="bibr">38</xref>&#x02013;<xref rid="b40-prbm-7-167" ref-type="bibr">40</xref> but models need to be studied and adjusted pragmatically. Other strategies must be considered, such as neuropsychological rehabilitation and social skill training, in order to build a more solid treatment combination. Some interventions do not produce the expected results, perhaps due to the design chosen (possibly the topics chosen for the PE played a key role here) or to the uncontrolled variables regarding psychotherapy research. Nonetheless, we can say that PE is not only welcome in the group of psychosocial interventions offered to bipolar subjects, but is an indispensable tool in the treatment of BD.</p></sec></body><back><fn-group><fn><p><bold>Disclosure</bold></p><p>The authors report no conflicts of interest in this work.</p></fn></fn-group><ref-list><title>References</title><ref id="b1-prbm-7-167"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giglio</surname><given-names>LM</given-names></name><name><surname>Magalh&#x000e3;es</surname><given-names>PV</given-names></name><name><surname>Kapczinski</surname><given-names>NS</given-names></name><name><surname>Walz</surname><given-names>JC</given-names></name><name><surname>Kapczinski</surname><given-names>F</given-names></name></person-group><article-title>Functional impact of biological rhythm disturbance in bipolar disorder</article-title><source>J Psychiatr Res</source><year>2010</year><volume>44</volume><issue>4</issue><fpage>220</fpage><lpage>223</lpage><pub-id pub-id-type="pmid">19758600</pub-id></element-citation></ref><ref id="b2-prbm-7-167"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kapczinski</surname><given-names>F</given-names></name><name><surname>Dias</surname><given-names>VV</given-names></name><name><surname>Kauer-Sant&#x02019;Anna</surname><given-names>M</given-names></name><etal/></person-group><article-title>Clinical implications of a staging model for bipolar disorders</article-title><source>Expert Rev Neurother</source><year>2009</year><volume>9</volume><issue>7</issue><fpage>957</fpage><lpage>966</lpage><pub-id pub-id-type="pmid">19589046</pub-id></element-citation></ref><ref id="b3-prbm-7-167"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harvey</surname><given-names>AG</given-names></name><name><surname>Talbot</surname><given-names>LS</given-names></name><name><surname>Gershon</surname><given-names>A</given-names></name></person-group><article-title>Sleep disturbance in bipolar disorder across the lifespan</article-title><source>Clin Psychol (New York)</source><year>2009</year><volume>16</volume><issue>2</issue><fpage>256</fpage><lpage>277</lpage><pub-id pub-id-type="pmid">22493520</pub-id></element-citation></ref><ref id="b4-prbm-7-167"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iwase</surname><given-names>T</given-names></name><name><surname>Kajimura</surname><given-names>N</given-names></name><name><surname>Uchiyama</surname><given-names>M</given-names></name><etal/></person-group><article-title>Mutation screening of the human clock gene in circadian rhythm sleep disorders</article-title><source>Psychiatry Res</source><year>2002</year><volume>109</volume><issue>2</issue><fpage>121</fpage><lpage>128</lpage><pub-id pub-id-type="pmid">11927136</pub-id></element-citation></ref><ref id="b5-prbm-7-167"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malkoff-Schwartz</surname><given-names>S</given-names></name><name><surname>Frank</surname><given-names>E</given-names></name><name><surname>Anderson</surname><given-names>BP</given-names></name><etal/></person-group><article-title>Social rhythm disruption and stressful life events in the onset of bipolar and unipolar episodes</article-title><source>Psychol Med</source><year>2000</year><volume>30</volume><issue>5</issue><fpage>1005</fpage><lpage>1016</lpage><pub-id pub-id-type="pmid">12027038</pub-id></element-citation></ref><ref id="b6-prbm-7-167"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Etain</surname><given-names>B</given-names></name><name><surname>Milhiet</surname><given-names>V</given-names></name><name><surname>Bellivier</surname><given-names>F</given-names></name><name><surname>Leboyer</surname><given-names>M</given-names></name></person-group><article-title>Genetics of circadian rhythms and mood spectrum disorders</article-title><source>Eur Neuropsychopharmacol</source><year>2011</year><volume>21</volume><issue>Suppl 4</issue><fpage>S676</fpage><lpage>S682</lpage><pub-id pub-id-type="pmid">21835597</pub-id></element-citation></ref><ref id="b7-prbm-7-167"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levenson</surname><given-names>JC</given-names></name><name><surname>Nusslock</surname><given-names>R</given-names></name><name><surname>Frank</surname><given-names>E</given-names></name></person-group><article-title>Life events, sleep disturbance, and mania: an integrated model</article-title><source>Clin Psychol Sci Pract</source><year>2013</year><volume>20</volume><issue>2</issue><fpage>195</fpage><lpage>210</lpage></element-citation></ref><ref id="b8-prbm-7-167"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cosgrove</surname><given-names>VE</given-names></name></person-group><article-title>Adjunctive psychotherapy for bipolar disorder</article-title><source>Focus</source><year>2011</year><volume>4</volume><issue>9</issue><fpage>449</fpage><lpage>454</lpage></element-citation></ref><ref id="b9-prbm-7-167"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goldner-Vukov</surname><given-names>M</given-names></name><name><surname>Moore</surname><given-names>LJ</given-names></name><name><surname>Cupina</surname><given-names>D</given-names></name></person-group><article-title>Bipolar disorder: from psychoeducational to existential group therapy</article-title><source>Australas Psychiatry</source><year>2007</year><volume>15</volume><issue>1</issue><fpage>30</fpage><lpage>34</lpage><pub-id pub-id-type="pmid">17464631</pub-id></element-citation></ref><ref id="b10-prbm-7-167"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gomes</surname><given-names>BC</given-names></name><name><surname>Lafer</surname><given-names>B</given-names></name></person-group><article-title>Group psychotherapy for bipolar disorder patients</article-title><source>Rev Psiq Clin</source><year>2007</year><volume>34</volume><issue>2</issue><fpage>84</fpage><lpage>89</lpage></element-citation></ref><ref id="b11-prbm-7-167"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miklowitz</surname><given-names>DJ</given-names></name><name><surname>George</surname><given-names>EL</given-names></name><name><surname>Richards</surname><given-names>JA</given-names></name><name><surname>Simoneau</surname><given-names>TL</given-names></name><name><surname>Suddath</surname><given-names>RL</given-names></name></person-group><article-title>A randomized study of family-focused psychoeducation and pharmacotherapy in the outpatient management of bipolar disorder</article-title><source>Arch Gen Psychiatry</source><year>2003</year><volume>60</volume><issue>9</issue><fpage>904</fpage><lpage>912</lpage><pub-id pub-id-type="pmid">12963672</pub-id></element-citation></ref><ref id="b12-prbm-7-167"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reinares</surname><given-names>M</given-names></name><name><surname>Colom</surname><given-names>F</given-names></name><name><surname>S&#x000e1;nchez-Moreno</surname><given-names>J</given-names></name><etal/></person-group><article-title>Impact of caregiver group psychoeducation on the course and outcome of bipolar patients in remission: a randomized controlled trial</article-title><source>Bipolar Disord</source><year>2008</year><volume>10</volume><issue>4</issue><fpage>511</fpage><lpage>519</lpage><pub-id pub-id-type="pmid">18452447</pub-id></element-citation></ref><ref id="b13-prbm-7-167"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lam</surname><given-names>DH</given-names></name><name><surname>Hayward</surname><given-names>P</given-names></name><name><surname>Watkins</surname><given-names>ER</given-names></name><name><surname>Wright</surname><given-names>K</given-names></name><name><surname>Sham</surname><given-names>P</given-names></name></person-group><article-title>Relapse prevention in patients with bipolar disorder: cognitive therapy outcome after 2 years</article-title><source>Am J Psychiatry</source><year>2005</year><volume>162</volume><issue>2</issue><fpage>324</fpage><lpage>329</lpage><pub-id pub-id-type="pmid">15677598</pub-id></element-citation></ref><ref id="b14-prbm-7-167"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frank</surname><given-names>E</given-names></name><name><surname>Kupfer</surname><given-names>DJ</given-names></name><name><surname>Thase</surname><given-names>ME</given-names></name><etal/></person-group><article-title>Two-year outcomes for interpersonal and social rhythm therapy in individuals with bipolar I disorder</article-title><source>Arch Gen Psychiatry</source><year>2005</year><volume>62</volume><issue>9</issue><fpage>996</fpage><lpage>1004</lpage><pub-id pub-id-type="pmid">16143731</pub-id></element-citation></ref><ref id="b15-prbm-7-167"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goodwin</surname><given-names>GM</given-names></name><collab>Consensus Group of the British Association for Psychopharmacology</collab></person-group><article-title>Evidence-based guidelines for treating bipolar disorder: revised second edition &#x02013; recommendations from the British Association for Psychopharmacology</article-title><source>J Psychopharmacol</source><year>2009</year><volume>23</volume><issue>4</issue><fpage>346</fpage><lpage>388</lpage><pub-id pub-id-type="pmid">19329543</pub-id></element-citation></ref><ref id="b16-prbm-7-167"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yatham</surname><given-names>LN</given-names></name><name><surname>Kennedy</surname><given-names>SH</given-names></name><name><surname>Parikh</surname><given-names>SV</given-names></name><etal/></person-group><article-title>Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013</article-title><source>Bipolar Disord</source><year>2013</year><volume>15</volume><issue>1</issue><fpage>1</fpage><lpage>44</lpage><pub-id pub-id-type="pmid">23237061</pub-id></element-citation></ref><ref id="b17-prbm-7-167"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanba</surname><given-names>S</given-names></name><name><surname>Kato</surname><given-names>T</given-names></name><name><surname>Terao</surname><given-names>T</given-names></name><name><surname>Yamada</surname><given-names>K</given-names></name><collab>Committee for Treatment Guidelines of Mood Disorders, Japanese Society of Mood Disorders, 2012</collab></person-group><article-title>Guideline for treatment of bipolar disorder by the Japanese Society of Mood Disorders, 2012</article-title><source>Psychiatry Clin Neurosci</source><year>2013</year><volume>67</volume><issue>5</issue><fpage>285</fpage><lpage>300</lpage><pub-id pub-id-type="pmid">23773266</pub-id></element-citation></ref><ref id="b18-prbm-7-167"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perry</surname><given-names>A</given-names></name><name><surname>Tarrier</surname><given-names>N</given-names></name><name><surname>Morriss</surname><given-names>R</given-names></name><name><surname>McCarthy</surname><given-names>E</given-names></name><name><surname>Limb</surname><given-names>K</given-names></name></person-group><article-title>Randomised controlled trial of efficacy of teaching patients with bipolar disorder to identify early symptoms of relapse and obtain treatment</article-title><source>BMJ</source><year>1999</year><volume>318</volume><issue>7177</issue><fpage>149</fpage><lpage>153</lpage><pub-id pub-id-type="pmid">9888904</pub-id></element-citation></ref><ref id="b19-prbm-7-167"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Colom</surname><given-names>F</given-names></name><name><surname>Vieta</surname><given-names>E</given-names></name><name><surname>Martinez-Aran</surname><given-names>A</given-names></name><etal/></person-group><article-title>A randomized trial on the efficacy of group psychoeducation in the prophylaxis of recurrences in bipolar patients whose disease is in remission</article-title><source>Arch Gen Psychiatry</source><year>2003</year><volume>60</volume><issue>4</issue><fpage>402</fpage><lpage>407</lpage><pub-id pub-id-type="pmid">12695318</pub-id></element-citation></ref><ref id="b20-prbm-7-167"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parikh</surname><given-names>SV</given-names></name><name><surname>Zaretsky</surname><given-names>A</given-names></name><name><surname>Beaulieu</surname><given-names>S</given-names></name><etal/></person-group><article-title>A randomized controlled trial of psychoeducation or cognitive-behavioral therapy in bipolar disorder: a Canadian Network for Mood and Anxiety treatments (CANMAT) study [CME]</article-title><source>J Clin Psychiatry</source><year>2012</year><volume>73</volume><issue>6</issue><fpage>803</fpage><lpage>810</lpage><pub-id pub-id-type="pmid">22795205</pub-id></element-citation></ref><ref id="b21-prbm-7-167"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hollon</surname><given-names>SD</given-names></name><name><surname>Ponniah</surname><given-names>K</given-names></name></person-group><article-title>A review of empirically supported psychological therapies for mood disorders in adults</article-title><source>Depress Anxiety</source><year>2010</year><volume>27</volume><issue>10</issue><fpage>891</fpage><lpage>932</lpage><pub-id pub-id-type="pmid">20830696</pub-id></element-citation></ref><ref id="b22-prbm-7-167"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miklowitz</surname><given-names>DJ</given-names></name></person-group><article-title>Adjunctive psychotherapy for bipolar disorder: state of the evidence</article-title><source>Am J Psychiatry</source><year>2008</year><volume>165</volume><issue>11</issue><fpage>1408</fpage><lpage>1419</lpage><pub-id pub-id-type="pmid">18794208</pub-id></element-citation></ref><ref id="b23-prbm-7-167"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scott</surname><given-names>J</given-names></name><name><surname>Colom</surname><given-names>F</given-names></name></person-group><article-title>Psychosocial treatments for bipolar disorders</article-title><source>Psychiatr Clin North Am</source><year>2005</year><volume>28</volume><issue>2</issue><fpage>371</fpage><lpage>384</lpage><pub-id pub-id-type="pmid">15826737</pub-id></element-citation></ref><ref id="b24-prbm-7-167"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Batista</surname><given-names>TA</given-names></name><name><surname>von Werne Baes</surname><given-names>C</given-names></name><name><surname>Juruena</surname><given-names>MF</given-names></name></person-group><article-title>Efficacy of psychoeducation in bipolar patients: systematic review of randomized trials</article-title><source>Psychol Neurosci</source><year>2011</year><volume>4</volume><issue>3</issue><fpage>409</fpage><lpage>416</lpage></element-citation></ref><ref id="b25-prbm-7-167"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kapczinski</surname><given-names>F</given-names></name><name><surname>Vieta</surname><given-names>E</given-names></name><name><surname>Andreazza</surname><given-names>AC</given-names></name><etal/></person-group><article-title>Allostatic load in bipolar disorder: implications for pathophysiology and treatment</article-title><source>Neurosci Biobehav Rev</source><year>2008</year><volume>32</volume><issue>4</issue><fpage>675</fpage><lpage>692</lpage><pub-id pub-id-type="pmid">18199480</pub-id></element-citation></ref><ref id="b26-prbm-7-167"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vieta</surname><given-names>E</given-names></name><name><surname>Popovic</surname><given-names>D</given-names></name><name><surname>Rosa</surname><given-names>AR</given-names></name><etal/></person-group><article-title>The clinical implications of cognitive impairment and allostatic load in bipolar disorder</article-title><source>Eur Psychiatry</source><year>2013</year><volume>28</volume><issue>1</issue><fpage>21</fpage><lpage>29</lpage><pub-id pub-id-type="pmid">22534552</pub-id></element-citation></ref><ref id="b27-prbm-7-167"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>da Silva Magalh&#x000e3;es</surname><given-names>PV</given-names></name><name><surname>Gomes</surname><given-names>FA</given-names></name><name><surname>Kunz</surname><given-names>M</given-names></name><name><surname>Kapczinski</surname><given-names>F</given-names></name></person-group><article-title>Birth-cohort and dual diagnosis effects on age-at-onset in Brazilian patients with bipolar I disorder</article-title><source>Acta Psychiatr Scand</source><year>2009</year><volume>120</volume><issue>6</issue><fpage>492</fpage><lpage>495</lpage><pub-id pub-id-type="pmid">19594482</pub-id></element-citation></ref><ref id="b28-prbm-7-167"><label>28</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Colom</surname><given-names>F</given-names></name><name><surname>Vieta</surname><given-names>E</given-names></name></person-group><source>Psychoeducation Manual for Bipolar Disorder</source><publisher-loc>New York</publisher-loc><publisher-name>The Cambridge University Press</publisher-name><year>2006</year></element-citation></ref><ref id="b29-prbm-7-167"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yatham</surname><given-names>LN</given-names></name><name><surname>Kauer-Sant&#x02019;Anna</surname><given-names>M</given-names></name><name><surname>Bond</surname><given-names>DJ</given-names></name><name><surname>Lam</surname><given-names>RW</given-names></name><name><surname>Torres</surname><given-names>I</given-names></name></person-group><article-title>Course and outcome after the first manic episode in patients with bipolar disorder: prospective 12-month data from the Systematic Treatment Optimization Program For Early Mania project</article-title><source>Can J Psychiatry</source><year>2009</year><volume>54</volume><issue>2</issue><fpage>105</fpage><lpage>112</lpage><pub-id pub-id-type="pmid">19254441</pub-id></element-citation></ref><ref id="b30-prbm-7-167"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Del-Ben</surname><given-names>CM</given-names></name><name><surname>Rodrigues</surname><given-names>CR</given-names></name><name><surname>Zuardi</surname><given-names>AW</given-names></name></person-group><article-title>Reliability of the Portuguese version of the structured clinical interview for DSM-III-R (SCID) in a Brazilian sample of psychiatric outpatients</article-title><source>Braz J Med Biol Res</source><year>1996</year><volume>29</volume><issue>12</issue><fpage>1675</fpage><lpage>1682</lpage><pub-id pub-id-type="pmid">9222432</pub-id></element-citation></ref><ref id="b31-prbm-7-167"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barros</surname><given-names>AJD</given-names></name><name><surname>Victora</surname><given-names>CG</given-names></name></person-group><article-title>Indicador econ&#x000f4;mico para o Brasil baseado no censo demogr&#x000e1;fico de 2000 [A nationwide wealth score based on the 2000 Brazilian demographic census.]</article-title><source>Revista de Sa&#x000fa;de P&#x000fa;blica</source><year>2005</year><volume>39</volume><issue>4</issue><fpage>523</fpage><lpage>529</lpage><comment>Portuguese</comment><pub-id pub-id-type="pmid">16113899</pub-id></element-citation></ref><ref id="b32-prbm-7-167"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moreno</surname><given-names>RA</given-names></name><name><surname>Moreno</surname><given-names>DH</given-names></name></person-group><article-title>Escalas de avalia&#x000e7;&#x000e3;o cl&#x000ed;nica em psiquiatria e psicofarmacologia: escalas de avalia&#x000e7;&#x000e3;o para depress&#x000e3;o de Hamilton (HAM-D) e Montgomery-Asberg (MADRS). [Clinical evaluation scales in psychiatry and psychopharmacology: Hamilton (HAM-D) and Montgomery-Asberg (MADRS) depression scales.]</article-title><source>Rev Psiquiatr Cl&#x000ed;n</source><year>1998</year><volume>25</volume><issue>5</issue><fpage>1</fpage><lpage>17</lpage></element-citation></ref><ref id="b33-prbm-7-167"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vilela</surname><given-names>JA</given-names></name><name><surname>Crippa</surname><given-names>JA</given-names></name><name><surname>Del-Ben</surname><given-names>CM</given-names></name><name><surname>Loureiro</surname><given-names>SR</given-names></name></person-group><article-title>Reliability and validity of a Portuguese version of the Young Mania Rating Scale</article-title><source>Braz J Med Biol Res</source><year>2005</year><volume>38</volume><issue>9</issue><fpage>1429</fpage><lpage>1439</lpage><pub-id pub-id-type="pmid">16138228</pub-id></element-citation></ref><ref id="b34-prbm-7-167"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giglio</surname><given-names>LMF</given-names></name><name><surname>Magalh&#x000e3;es</surname><given-names>PV</given-names></name><name><surname>Andreazza</surname><given-names>AC</given-names></name><etal/></person-group><article-title>Development and use of a biological rhythm interview</article-title><source>J Affect Disord</source><year>2009</year><volume>118</volume><issue>1&#x02013;3</issue><fpage>161</fpage><lpage>165</lpage><pub-id pub-id-type="pmid">19232743</pub-id></element-citation></ref><ref id="b35-prbm-7-167"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Barros Pellegrinelli</surname><given-names>KB</given-names></name><name><surname>de O Costa</surname><given-names>LF</given-names></name><name><surname>Silval</surname><given-names>KI</given-names></name><etal/></person-group><article-title>Efficacy of psychoeducation on symptomatic and functional recovery in bipolar disorder</article-title><source>Acta Psychiatr Scand</source><year>2013</year><volume>127</volume><issue>2</issue><fpage>153</fpage><lpage>158</lpage><pub-id pub-id-type="pmid">22943487</pub-id></element-citation></ref><ref id="b36-prbm-7-167"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miklowitz</surname><given-names>DJ</given-names></name><name><surname>Price</surname><given-names>J</given-names></name><name><surname>Holmes</surname><given-names>EA</given-names></name><etal/></person-group><article-title>Facilitated Integrated Mood Management for adults with bipolar disorder</article-title><source>Bipolar Disord</source><year>2012</year><volume>14</volume><issue>2</issue><fpage>185</fpage><lpage>197</lpage><pub-id pub-id-type="pmid">22420594</pub-id></element-citation></ref><ref id="b37-prbm-7-167"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vieta</surname><given-names>E</given-names></name><name><surname>Pacchiarotti</surname><given-names>I</given-names></name><name><surname>Scott</surname><given-names>J</given-names></name><name><surname>S&#x000e1;nchez-Moreno</surname><given-names>J</given-names></name><name><surname>Di Marzo</surname><given-names>S</given-names></name><name><surname>Colom</surname><given-names>F</given-names></name></person-group><article-title>Evidence-based research on the efficacy of psychologic interventions in bipolar disorders: a critical review</article-title><source>Curr Psychiatry Rep</source><year>2005</year><volume>7</volume><issue>6</issue><fpage>449</fpage><lpage>455</lpage><pub-id pub-id-type="pmid">16318823</pub-id></element-citation></ref><ref id="b38-prbm-7-167"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Castle</surname><given-names>D</given-names></name><name><surname>White</surname><given-names>C</given-names></name><name><surname>Chamberlain</surname><given-names>J</given-names></name><etal/></person-group><article-title>Group-based psychosocial intervention for bipolar disorder: randomised controlled trial</article-title><source>Br J Psychiatry</source><year>2010</year><volume>196</volume><issue>5</issue><fpage>383</fpage><lpage>388</lpage><pub-id pub-id-type="pmid">20435965</pub-id></element-citation></ref><ref id="b39-prbm-7-167"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Colom</surname><given-names>F</given-names></name><name><surname>Reinares</surname><given-names>M</given-names></name><name><surname>Pacchiarotti</surname><given-names>I</given-names></name><etal/></person-group><article-title>Has number of previous episodes any effect on response to group psychoeducation in bipolar patients? A 5-year follow-up post hoc analysis</article-title><source>Acta Neuropsychiatr</source><year>2010</year><volume>22</volume><issue>2</issue><fpage>50</fpage><lpage>53</lpage></element-citation></ref><ref id="b40-prbm-7-167"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reinares</surname><given-names>M</given-names></name><name><surname>Colom</surname><given-names>F</given-names></name><name><surname>Rosa</surname><given-names>AR</given-names></name><etal/></person-group><article-title>The impact of staging bipolar disorder on treatment outcome of family psychoeducation</article-title><source>J Affect Disord</source><year>2010</year><volume>123</volume><issue>1&#x02013;3</issue><fpage>81</fpage><lpage>86</lpage><pub-id pub-id-type="pmid">19853922</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="f1-prbm-7-167" position="float"><label>Figure 1</label><caption><p>Participant flowchart.</p></caption><graphic xlink:href="prbm-7-167Fig1"/></fig><table-wrap id="t1-prbm-7-167" position="float"><label>Table 1</label><caption><p>Baseline demographic and clinical characteristics of each group</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top" rowspan="1" colspan="1">Demographic and clinical characteristics</th><th align="left" valign="top" rowspan="1" colspan="1">Standard intervention n=29</th><th align="left" valign="top" rowspan="1" colspan="1">Combined intervention n=32</th><th align="left" valign="top" rowspan="1" colspan="1"><italic>P</italic>-value</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Sex</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">0.768</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Female</td><td align="left" valign="top" rowspan="1" colspan="1">21 (72.4%)</td><td align="left" valign="top" rowspan="1" colspan="1">21 (65.6%)</td><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Male</td><td align="left" valign="top" rowspan="1" colspan="1">8 (27.6%)</td><td align="left" valign="top" rowspan="1" colspan="1">11 (34.4%)</td><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Age (years)</td><td align="left" valign="top" rowspan="1" colspan="1">24.03 (&#x000b1;3.57)</td><td align="left" valign="top" rowspan="1" colspan="1">24.09 (&#x000b1;3.90)</td><td align="left" valign="top" rowspan="1" colspan="1">0.951</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Education (years)</td><td align="left" valign="top" rowspan="1" colspan="1">12.30 (&#x000b1;3.33)</td><td align="left" valign="top" rowspan="1" colspan="1">11.64 (&#x000b1;3.13)</td><td align="left" valign="top" rowspan="1" colspan="1">0.467</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Economic index<xref ref-type="table-fn" rid="tfn1-prbm-7-167">*</xref></td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">0.041</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Low</td><td align="left" valign="top" rowspan="1" colspan="1">6 (35.3%)</td><td align="left" valign="top" rowspan="1" colspan="1">11 (64.7%)</td><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Intermediate</td><td align="left" valign="top" rowspan="1" colspan="1">9 (50.0%)</td><td align="left" valign="top" rowspan="1" colspan="1">9 (50.0%)</td><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;High</td><td align="left" valign="top" rowspan="1" colspan="1">12 (70.6%)</td><td align="left" valign="top" rowspan="1" colspan="1">5 (29.4%)</td><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Years of illness</td><td align="left" valign="top" rowspan="1" colspan="1">5.48 (&#x000b1;4.26)</td><td align="left" valign="top" rowspan="1" colspan="1">5.06 (&#x000b1;4.26)</td><td align="left" valign="top" rowspan="1" colspan="1">0.702</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Current episode</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">0.466</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Euthymia</td><td align="left" valign="top" rowspan="1" colspan="1">2 (6.9%)</td><td align="left" valign="top" rowspan="1" colspan="1">2 (6.3%)</td><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Depression</td><td align="left" valign="top" rowspan="1" colspan="1">17 (18.6%)</td><td align="left" valign="top" rowspan="1" colspan="1">18 (56.3%)</td><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Hypomania</td><td align="left" valign="top" rowspan="1" colspan="1">1 (3.4%)</td><td align="left" valign="top" rowspan="1" colspan="1">2 (6.3%)</td><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Mania</td><td align="left" valign="top" rowspan="1" colspan="1">1 (3.4%)</td><td align="left" valign="top" rowspan="1" colspan="1">5 (15.6%)</td><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Mixed</td><td align="left" valign="top" rowspan="1" colspan="1">8 (27.6%)</td><td align="left" valign="top" rowspan="1" colspan="1">5 (15.6%)</td><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Depressive symptoms (HDRS)</td><td align="left" valign="top" rowspan="1" colspan="1">13.07 (&#x000b1;6.22)</td><td align="left" valign="top" rowspan="1" colspan="1">12.22 (&#x000b1;5.96)</td><td align="left" valign="top" rowspan="1" colspan="1">0.589</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Manic symptoms (YMRS)</td><td align="left" valign="top" rowspan="1" colspan="1">5.83 (&#x000b1;6.58)</td><td align="left" valign="top" rowspan="1" colspan="1">7.03 (&#x000b1;8.63)</td><td align="left" valign="top" rowspan="1" colspan="1">0.541</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Biological rhythm (BRIAN)</td><td align="left" valign="top" rowspan="1" colspan="1">47.43 (&#x000b1;9.46)</td><td align="left" valign="top" rowspan="1" colspan="1">44.84 (&#x000b1;11.63)</td><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Sleep</td><td align="left" valign="top" rowspan="1" colspan="1">14.38 (&#x000b1;3.24)</td><td align="left" valign="top" rowspan="1" colspan="1">13.81 (&#x000b1;6.45)</td><td align="left" valign="top" rowspan="1" colspan="1">0.662</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Activity</td><td align="left" valign="top" rowspan="1" colspan="1">12.86 (&#x000b1;3.88)</td><td align="left" valign="top" rowspan="1" colspan="1">11.16 (&#x000b1;3.62)</td><td align="left" valign="top" rowspan="1" colspan="1">0.082</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Social rhythm</td><td align="left" valign="top" rowspan="1" colspan="1">10.69 (&#x000b1;2.20)</td><td align="left" valign="top" rowspan="1" colspan="1">8.56 (&#x000b1;1.81)</td><td align="left" valign="top" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Eating</td><td align="left" valign="top" rowspan="1" colspan="1">11.07 (&#x000b1;2.85)</td><td align="left" valign="top" rowspan="1" colspan="1">9.97 (&#x000b1;3.58)</td><td align="left" valign="top" rowspan="1" colspan="1">0.193</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Total</td><td align="left" valign="top" rowspan="1" colspan="1">49.00 (&#x000b1;8.78)</td><td align="left" valign="top" rowspan="1" colspan="1">43.50 (&#x000b1;11.55)</td><td align="left" valign="top" rowspan="1" colspan="1">0.040</td></tr></tbody></table><table-wrap-foot><fn><p><bold>Note:</bold></p></fn><fn id="tfn1-prbm-7-167"><label>*</label><p>Missing data in this category.</p></fn><fn id="tfn2-prbm-7-167"><p><bold>Abbreviations:</bold> BRIAN, Biological Rhythm Interview of Assessment in Neuropsychiatry; HDRS, Hamilton Depression Rating Scale; YMRS, Young Mania Rating Scale.</p></fn></table-wrap-foot></table-wrap><table-wrap id="t2-prbm-7-167" position="float"><label>Table 2</label><caption><p>Outcome results for each group</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top" rowspan="1" colspan="1">Outcomes</th><th align="left" valign="top" rowspan="1" colspan="1">Postintervention</th><th align="left" valign="top" rowspan="1" colspan="1">Differences between means baseline (95%CI)</th><th align="left" valign="top" rowspan="1" colspan="1"><italic>P</italic>-value</th><th align="left" valign="top" rowspan="1" colspan="1">Effect size <italic>r</italic></th></tr></thead><tbody><tr><td colspan="5" align="left" valign="top" rowspan="1">Total sample</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Depression symptoms</td><td align="left" valign="top" rowspan="1" colspan="1">12.57 (&#x000b1;5.79)</td><td align="left" valign="top" rowspan="1" colspan="1">2.59 (1.16; 4.02)</td><td align="left" valign="top" rowspan="1" colspan="1">0.001<xref ref-type="table-fn" rid="tfn3-prbm-7-167">*</xref></td><td align="left" valign="top" rowspan="1" colspan="1">0.424</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Manic symptoms</td><td align="left" valign="top" rowspan="1" colspan="1">5.11 (&#x000b1;5.18)</td><td align="left" valign="top" rowspan="1" colspan="1">1.34 (&#x02212;0.72; 3.41)</td><td align="left" valign="top" rowspan="1" colspan="1">0.198</td><td align="left" valign="top" rowspan="1" colspan="1">0.167</td></tr><tr><td colspan="5" align="left" valign="top" rowspan="1">&#x02003;Biological rhythm</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;&#x02003;Sleep</td><td align="left" valign="top" rowspan="1" colspan="1">12.82 (&#x000b1;3.58)</td><td align="left" valign="top" rowspan="1" colspan="1">1.26 (&#x02212;0.17; 2.70)</td><td align="left" valign="top" rowspan="1" colspan="1">0.083</td><td align="left" valign="top" rowspan="1" colspan="1">0.222</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;&#x02003;Activity</td><td align="left" valign="top" rowspan="1" colspan="1">9.87 (&#x000b1;3.36)</td><td align="left" valign="top" rowspan="1" colspan="1">2.10 (0.82; 3.38)</td><td align="left" valign="top" rowspan="1" colspan="1">0.002<xref ref-type="table-fn" rid="tfn3-prbm-7-167">*</xref></td><td align="left" valign="top" rowspan="1" colspan="1">0.390</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;&#x02003;Social rhythm</td><td align="left" valign="top" rowspan="1" colspan="1">8.82 (&#x000b1;2.58)</td><td align="left" valign="top" rowspan="1" colspan="1">0.75 (&#x02212;0.04; 1.54)</td><td align="left" valign="top" rowspan="1" colspan="1">0.061</td><td align="left" valign="top" rowspan="1" colspan="1">0.239</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;&#x02003;Eating</td><td align="left" valign="top" rowspan="1" colspan="1">9.66 (&#x000b1;3.57)</td><td align="left" valign="top" rowspan="1" colspan="1">0.84 (&#x02212;0.31; 1.98)</td><td align="left" valign="top" rowspan="1" colspan="1">0.150</td><td align="left" valign="top" rowspan="1" colspan="1">0.185</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;&#x02003;Total</td><td align="left" valign="top" rowspan="1" colspan="1">41.16 (&#x000b1;9.17)</td><td align="left" valign="top" rowspan="1" colspan="1">4.95 (1.24; 8.66)</td><td align="left" valign="top" rowspan="1" colspan="1">0.010<xref ref-type="table-fn" rid="tfn3-prbm-7-167">*</xref></td><td align="left" valign="top" rowspan="1" colspan="1">0.326</td></tr><tr><td colspan="5" align="left" valign="top" rowspan="1">Standard intervention (n=29)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Depression symptoms</td><td align="left" valign="top" rowspan="1" colspan="1">12.62 (&#x000b1;5.49)</td><td align="left" valign="top" rowspan="1" colspan="1">3.55 (1.09; 6.01)</td><td align="left" valign="top" rowspan="1" colspan="1">0.006<xref ref-type="table-fn" rid="tfn3-prbm-7-167">*</xref></td><td align="left" valign="top" rowspan="1" colspan="1">0.487</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Manic symptoms</td><td align="left" valign="top" rowspan="1" colspan="1">5.62 (&#x000b1;4.40)</td><td align="left" valign="top" rowspan="1" colspan="1">0.21 (&#x02212;2.88; 3.30)</td><td align="left" valign="top" rowspan="1" colspan="1">0.892</td><td align="left" valign="top" rowspan="1" colspan="1">0.026</td></tr><tr><td colspan="5" align="left" valign="top" rowspan="1">&#x02003;Biological rhythm</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;&#x02003;Sleep</td><td align="left" valign="top" rowspan="1" colspan="1">12.17 (&#x000b1;3.62)</td><td align="left" valign="top" rowspan="1" colspan="1">2.21 (0.52; 3.89)</td><td align="left" valign="top" rowspan="1" colspan="1">0.012<xref ref-type="table-fn" rid="tfn3-prbm-7-167">*</xref></td><td align="left" valign="top" rowspan="1" colspan="1">0.451</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;&#x02003;Activity</td><td align="left" valign="top" rowspan="1" colspan="1">9.41 (&#x000b1;3.41)</td><td align="left" valign="top" rowspan="1" colspan="1">3.45 (1.66; 5.23)</td><td align="left" valign="top" rowspan="1" colspan="1">&#x0003c;0.001<xref ref-type="table-fn" rid="tfn3-prbm-7-167">*</xref></td><td align="left" valign="top" rowspan="1" colspan="1">0.599</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;&#x02003;Social rhythm</td><td align="left" valign="top" rowspan="1" colspan="1">8.62 (&#x000b1;2.87)</td><td align="left" valign="top" rowspan="1" colspan="1">2.07 (0.84; 3.30)</td><td align="left" valign="top" rowspan="1" colspan="1">0.002<xref ref-type="table-fn" rid="tfn3-prbm-7-167">*</xref></td><td align="left" valign="top" rowspan="1" colspan="1">0.545</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;&#x02003;Eating</td><td align="left" valign="top" rowspan="1" colspan="1">9. 62 (&#x000b1;3.71)</td><td align="left" valign="top" rowspan="1" colspan="1">1.45 (&#x02212;0.15; 3.05)</td><td align="left" valign="top" rowspan="1" colspan="1">0.074</td><td align="left" valign="top" rowspan="1" colspan="1">0.331</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;&#x02003;Total</td><td align="left" valign="top" rowspan="1" colspan="1">39.83 (&#x000b1;9.18)</td><td align="left" valign="top" rowspan="1" colspan="1">9.17 (4.04; 14.31)</td><td align="left" valign="top" rowspan="1" colspan="1">0.001<xref ref-type="table-fn" rid="tfn3-prbm-7-167">*</xref></td><td align="left" valign="top" rowspan="1" colspan="1">0.569</td></tr><tr><td colspan="5" align="left" valign="top" rowspan="1">Combined intervention (n=32)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Depression symptoms</td><td align="left" valign="top" rowspan="1" colspan="1">12.53 (&#x000b1;6.14)</td><td align="left" valign="top" rowspan="1" colspan="1">1.72 (0.07; 3.36)</td><td align="left" valign="top" rowspan="1" colspan="1">0.041<xref ref-type="table-fn" rid="tfn3-prbm-7-167">*</xref></td><td align="left" valign="top" rowspan="1" colspan="1">0.357</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Manic symptoms</td><td align="left" valign="top" rowspan="1" colspan="1">4.66 (&#x000b1;5.82)</td><td align="left" valign="top" rowspan="1" colspan="1">2.37 (&#x02212;0.50; 5.25)</td><td align="left" valign="top" rowspan="1" colspan="1">0.102</td><td align="left" valign="top" rowspan="1" colspan="1">0.289</td></tr><tr><td colspan="5" align="left" valign="top" rowspan="1">&#x02003;Biological rhythm</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;&#x02003;Sleep</td><td align="left" valign="top" rowspan="1" colspan="1">13.41 (&#x000b1;3.49)</td><td align="left" valign="top" rowspan="1" colspan="1">0.41 (&#x02212;1.91; 2.72)</td><td align="left" valign="top" rowspan="1" colspan="1">0.723</td><td align="left" valign="top" rowspan="1" colspan="1">0.064</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;&#x02003;Activity</td><td align="left" valign="top" rowspan="1" colspan="1">10.28 (&#x000b1;3.31)</td><td align="left" valign="top" rowspan="1" colspan="1">0.87 (&#x02212;0.93; 2.68)</td><td align="left" valign="top" rowspan="1" colspan="1">0.330</td><td align="left" valign="top" rowspan="1" colspan="1">0.175</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;&#x02003;Social rhythm</td><td align="left" valign="top" rowspan="1" colspan="1">9.00 (&#x000b1;2.33)</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02212;0.44 (&#x02212;1.31; 0.44)</td><td align="left" valign="top" rowspan="1" colspan="1">0.315</td><td align="left" valign="top" rowspan="1" colspan="1">0.180</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;&#x02003;Eating</td><td align="left" valign="top" rowspan="1" colspan="1">9.69 (&#x000b1;3.49)</td><td align="left" valign="top" rowspan="1" colspan="1">0.28 (&#x02212;1.41; 1.98)</td><td align="left" valign="top" rowspan="1" colspan="1">0.738</td><td align="left" valign="top" rowspan="1" colspan="1">0.060</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;&#x02003;Total</td><td align="left" valign="top" rowspan="1" colspan="1">42.38 (&#x000b1;9.14)</td><td align="left" valign="top" rowspan="1" colspan="1">1.12 (&#x02212;4.10; 6.35)</td><td align="left" valign="top" rowspan="1" colspan="1">0.664</td><td align="left" valign="top" rowspan="1" colspan="1">0.079</td></tr></tbody></table><table-wrap-foot><fn><p><bold>Note:</bold></p></fn><fn id="tfn3-prbm-7-167"><label>*</label><p><italic>P</italic>-value &#x0003c;0.05</p></fn><fn id="tfn4-prbm-7-167"><p><bold>Abbreviation:</bold> CI, confidence interval.</p></fn></table-wrap-foot></table-wrap><table-wrap id="t3-prbm-7-167" position="float"><label>Table 3</label><caption><p>Crude and adjusted linear regression for symptoms remission and biological rhythm regulation comparisons between intervention groups</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top" rowspan="2" colspan="1">Outcomes</th><th colspan="2" align="left" valign="top" rowspan="1">Crude
<hr/></th><th colspan="2" align="left" valign="top" rowspan="1">Adjusted for economic index
<hr/></th></tr><tr><th align="left" valign="top" rowspan="1" colspan="1">B (95% CI)</th><th align="left" valign="top" rowspan="1" colspan="1"><italic>P</italic>-value</th><th align="left" valign="top" rowspan="1" colspan="1">B (95% CI)</th><th align="left" valign="top" rowspan="1" colspan="1"><italic>P</italic>-value</th></tr></thead><tbody><tr><td colspan="5" align="left" valign="top" rowspan="1">Depression symptom remission</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Combined intervention</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02212;1.07 (&#x02212;4.91; 2.77)</td><td align="left" valign="top" rowspan="1" colspan="1">0.578</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02212;1.86 (&#x02212;6.34; 2.61)</td><td align="left" valign="top" rowspan="1" colspan="1">0.404</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Manic symptom remission</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Combined intervention</td><td align="left" valign="top" rowspan="1" colspan="1">3.78 (&#x02212;1.88; 9.42)</td><td align="left" valign="top" rowspan="1" colspan="1">0.185</td><td align="left" valign="top" rowspan="1" colspan="1">5.93 (&#x02212;0.28; &#x02212;12.15)</td><td align="left" valign="top" rowspan="1" colspan="1">0.061</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Biological rhythm regulation</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Combined intervention</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02212;10.89 (&#x02212;18.84; &#x02212;2.95)</td><td align="left" valign="top" rowspan="1" colspan="1">0.008</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02212;10.84 (&#x02212;20.61; &#x02212;1.07)</td><td align="left" valign="top" rowspan="1" colspan="1">0.031</td></tr></tbody></table><table-wrap-foot><fn id="tfn5-prbm-7-167"><p><bold>Abbreviations:</bold> CI, confidence interval; B, baseline.</p></fn></table-wrap-foot></table-wrap></floats-group></article>